RSVP

Current Trends in the Management of Early Stage, Resectable Non-Small Cell Lung Cancer

Churchill’s Steakhouse
165 South Post Street
Spokane, WA
Tuesday November 7

The treatment of lung cancer is rapidly evolving.  Minimally invasive surgical techniques are shifting towards robotics and more limited anatomic lung resections while medical therapies have expanded with immunotherapy and targeted therapy.  Until recently, new systemic therapies were mostly evaluated in the metastatic setting, but there have been several recent studies in resectable lung cancer that have shown impressive clinical outcomes.  At this meeting we hope to provide a detailed analysis of the clinical studies, and provoke a robust discussion regarding the multi-disciplinary care of these patients, in hopes of improving outcomes for NSCLC patients in the Spokane region.

5:00 - 6:00

Doors Open & Welcome Reception

6:00 - 6:10

Opening remarks from the co-chairs
Jessica Hellyer, MD
Alexi Matousek, MD

6:10 - 6:35

Is Anatomical Segmentectomy The Gold Standard For Resection of Patients With Early-Stage NSCLC?

Eric Vallieres, MD

6:35 - 7:00

Improving Outcomes With Robotic Lung Resection and ION Bronchoscopy

Alexi Matousek, MD

7:00 - 7:30

Serve Dinner

7:30 - 8:00

Systemic Therapy in Resectable Lung Cancer: When is Earlier Better?

Sid Devarakonda, MD
Director, Thoracic Medical Oncology

8:00 - 8:30

Panel Discussion and Q&A

Alexi Matousek, MD
Jessica Hellyer, MD
Eric Vallieres, MD
Sid Devarakonda, MD

8:30 - 8:40

Closing Remarks

Jessica Hellyer, MD
Alexi Matousek, MD

This meeting is supported by: